ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $34,432,000 | +5.3% | 23,583,115 | +2.4% | 0.01% | 0.0% |
| Q4 2016 | $32,710,000 | -26.9% | 23,035,452 | -9.9% | 0.01% | -27.3% |
| Q3 2016 | $44,748,000 | -2.1% | 25,570,751 | -4.3% | 0.01% | -8.3% |
| Q2 2016 | $45,701,000 | -13.3% | 26,725,936 | -0.2% | 0.01% | -14.3% |
| Q1 2016 | $52,741,000 | +10.9% | 26,772,026 | +7.0% | 0.01% | +16.7% |
| Q4 2015 | $47,558,000 | -26.6% | 25,030,751 | -26.2% | 0.01% | -33.3% |
| Q3 2015 | $64,767,000 | -58.8% | 33,909,459 | +0.1% | 0.02% | -56.1% |
| Q2 2015 | $157,230,000 | +6.4% | 33,885,551 | +0.2% | 0.04% | +7.9% |
| Q1 2015 | $147,719,000 | +46.3% | 33,802,464 | +16.2% | 0.04% | +40.7% |
| Q4 2014 | $100,984,000 | -18.7% | 29,101,919 | -1.8% | 0.03% | -20.6% |
| Q3 2014 | $124,141,000 | -24.1% | 29,627,959 | +6.2% | 0.03% | -22.7% |
| Q2 2014 | $163,455,000 | -5.8% | 27,893,387 | +1.2% | 0.04% | -8.3% |
| Q1 2014 | $173,561,000 | -1.2% | 27,549,128 | -8.2% | 0.05% | -5.9% |
| Q4 2013 | $175,640,000 | +21.3% | 30,024,014 | +9.3% | 0.05% | +13.3% |
| Q3 2013 | $144,781,000 | -24.2% | 27,472,516 | +10.7% | 0.04% | -27.4% |
| Q2 2013 | $191,028,000 | – | 24,808,878 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |